ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AKBA Akebia Therapeutics Inc

1,05
0,00 (0,00%)
Última atualização: 10:43:58
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Akebia Therapeutics Inc AKBA NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 1,05 10:43:58
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,04 1,03 1,05 1,05
mais cotações »

Notícias Recentes

Data Hora Fonte Título
03/06/202417:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
23/05/202409:00PRNUSAkebia Therapeutics to Present at the Jefferies Global..
14/05/202409:00PRNUSAkebia Therapeutics to Present at the 2nd Annual HCW..
09/05/202408:00PRNUSAkebia Therapeutics Reports First Quarter 2024 Financial..
02/05/202409:30PRNUSAkebia Therapeutics to Report First Quarter 2024 Financial..
01/05/202417:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
02/04/202417:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
27/03/202421:26PRNUSAkebia Receives FDA Approval of Vafseo® (vadadustat) Tablets..
14/03/202417:15PRNUSAkebia Therapeutics Reports Fourth Quarter and Full Year..
11/03/202418:05PRNUSAkebia Therapeutics to Report Fourth Quarter and Full Year..
01/03/202418:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
02/02/202418:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
30/01/202410:00PRNUSAkebia Secures $55 Million Term Loan Financing
09/01/202410:30PRNUSAkebia Therapeutics Announces Appointment of Nicholas Grund..
02/01/202418:30PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
20/12/202310:00PRNUSAkebia Therapeutics to Present at the 42nd Annual J.P...
01/12/202318:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
20/11/202310:00PRNUSAkebia Therapeutics to Present at Piper Sandler Healthcare..
08/11/202309:30PRNUSAkebia Therapeutics Reports Third Quarter 2023 Financial..
02/11/202317:30PRNUSAkebia Therapeutics Announces Favorable Payment Term..
01/11/202317:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
31/10/202309:00PRNUSAkebia Therapeutics to Report Third Quarter 2023 Financial..
25/10/202309:30PRNUSAkebia Receives FDA Acceptance of Resubmission to NDA of..
18/10/202309:00PRNUSAkebia Therapeutics Announces Five Poster Presentations at..
03/10/202317:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
28/09/202309:00PRNUSAkebia Therapeutics Resubmits New Drug Application to the..
26/09/202309:00PRNUSAkebia Announces Approval of Vafseo® (vadadustat) in..
06/09/202309:00PRNUSAkebia Therapeutics to Present at H.C. Wainwright Global..
05/09/202317:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
25/08/202309:09PRNUSAkebia Therapeutics Reports Second Quarter 2023 Financial..
24/08/202309:00PRNUSAkebia Therapeutics Expects to Resubmit Vadadustat NDA in..
23/08/202317:35PRNUSAkebia Therapeutics to Report Second Quarter Financial..
17/08/202317:05PRNUSAkebia Therapeutics to Report Second Quarter Financial..
10/08/202318:40PRNUSAkebia Therapeutics Provides Update on Form 10-Q Filing
01/08/202317:30PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
19/07/202308:45PRNUSAkebia Therapeutics to Present at the H.C. Wainwright Kidney..
18/07/202308:45PRNUSAkebia Therapeutics Completed Type A Meeting with the FDA..
05/07/202317:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
29/06/202309:00PRNUSAkebia Therapeutics Announces Positive Top-Line Results of..
20/06/202309:00PRNUSAkebia Announces Swissmedic Approval of Vafseo® (vadadustat)

Seu Histórico Recente

Delayed Upgrade Clock